| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.58 | 0.04 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.36 | 0.02 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.28 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.02 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.25 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-08 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |